» Articles » PMID: 38673894

Higher Seasonal Variation of Systemic Inflammation in Bipolar Disorder

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Apr 27
PMID 38673894
Authors
Affiliations
Soon will be listed here.
Abstract

Seasonal rhythms affect the immune system. Evidence supports the involvement of immuno-inflammatory mechanisms in bipolar disorder (BD), with the neutrophil to lymphocyte ratio (NLR), and the systemic immune-inflammatory index (SII; platelets × neutrophils/lymphocytes) consistently reported to be higher in patients with BD than in HC, but seasonal rhythms of innate and adaptive immunity have never been studied. We retrospectively studied NLR and SII in 824 participants divided into three groups: 321 consecutively admitted inpatients affected by a major depressive episode in course of BD, and 255 consecutively admitted inpatients affected by obsessive-compulsive disorder (OCD; positive psychiatric control), and 248 healthy controls (HC). Patients with BD showed markedly higher markers of systemic inflammation in autumn and winter, but not in spring and summer, in respect to both HC and patients with OCD, thus suggesting a specific effect of season on inflammatory markers in BD, independent of a shared hospital setting and drug treatment. Given that systemic inflammation is emerging as a new marker and as target for treatment in depressive disorders, we suggest that seasonal rhythms should be considered for tailoring antidepressant immuno-modulatory treatments in a precision medicine approach.

References
1.
Wyse C, OMalley G, Coogan A, McConkey S, Smith D . Seasonal and daytime variation in multiple immune parameters in humans: Evidence from 329,261 participants of the UK Biobank cohort. iScience. 2021; 24(4):102255. PMC: 8010467. DOI: 10.1016/j.isci.2021.102255. View

2.
McWhinney S, Abe C, Alda M, Benedetti F, Boen E, Bonnin C . Mega-analysis of association between obesity and cortical morphology in bipolar disorders: ENIGMA study in 2832 participants. Psychol Med. 2023; 53(14):6743-6753. PMC: 10600817. DOI: 10.1017/S0033291723000223. View

3.
Mazza M, Lucchi S, Tringali A, Rossetti A, Botti E, Clerici M . Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018; 84(Pt A):229-236. DOI: 10.1016/j.pnpbp.2018.03.012. View

4.
Raison C, Rutherford R, Woolwine B, Shuo C, Schettler P, Drake D . A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2012; 70(1):31-41. PMC: 4015348. DOI: 10.1001/2013.jamapsychiatry.4. View

5.
Post R, Leverich G, Altshuler L, Frye M, Suppes T, McElroy S . Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. J Clin Psychiatry. 2012; 73(7):924-30. DOI: 10.4088/JCP.11m07396. View